Follow us on:

US Broker Ratings

Valmont Industries, Inc. Share Price Target ‘$288.33’, now 6.0% Upside Potential

June 28, 2024

Vertex Pharmaceuticals Incorporated Share Price Target ‘$473.61’, now -.1% Downside Potential

June 28, 2024

Ovintiv Inc. Share Price Target ‘$63.16’, now 37.4% Upside Potential

June 28, 2024

TopBuild Corp. Share Price Target ‘$465.00’, now 21.9% Upside Potential

June 28, 2024

First American Financial Corporation Share Price Target ‘$66.00’, now 24.2% Upside Potential

June 28, 2024

Mohawk Industries, Inc. Share Price Target ‘$126.63’, now 18.6% Upside Potential

June 28, 2024

Axalta Coating Systems Ltd. Share Price Target ‘$40.06’, now 17.8% Upside Potential

June 28, 2024

Merck & Co., Inc. Share Price Target ‘$142.98’, now 8.7% Upside Potential

June 28, 2024

Polaris Inc. Share Price Target ‘$97.33’, now 24.6% Upside Potential

June 28, 2024

MDU Resources Group, Inc. Share Price Target ‘$26.50’, now 5.4% Upside Potential

June 28, 2024

Range Resources Corporation Share Price Target ‘$38.62’, now 15.1% Upside Potential

June 28, 2024

Zoetis Inc. Share Price Target ‘$212.29’, now 24.2% Upside Potential

June 28, 2024

Regal Rexnord Corporation Share Price Target ‘$196.88’, now 43.9% Upside Potential

June 28, 2024

The Middleby Corporation Share Price Target ‘$168.67’, now 37.3% Upside Potential

June 28, 2024

Flowers Foods, Inc. Share Price Target ‘$24.71’, now 9.9% Upside Potential

June 28, 2024

Inspire Medical Systems, Inc. Share Price Target ‘$246.00’, now 78.4% Upside Potential

June 28, 2024

Norwegian Cruise Line Holdings Ltd. Share Price Target ‘$20.81’, now 11.9% Upside Potential

June 28, 2024

Commerce Bancshares, Inc. Share Price Target ‘$58.25’, now 7.2% Upside Potential

June 28, 2024

HashiCorp, Inc. Share Price Target ‘$34.50’, now 3.0% Upside Potential

June 28, 2024

Abbott Laboratories Share Price Target ‘$125.18’, now 19.4% Upside Potential

June 28, 2024

News and Interview Alerts

Company Presentations

Q&As

Hardman & Co

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

Green News

Drax Group completes £300m buyback and launches £75m extension tranche

9 October 2025

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

BrokerTalk

Funds

Fidelity

Investing in Europe: Why investors should remain positive

8 October 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

The Diverse Income Trust Gervais Williams Eyes Big Gains from Gold, Gas and Tech (Video)

3 October 2025

View all Funds, Market Insights and news >>

FTSE 100 News

Ashtead Group

Ashtead Group achieves strong quarter with ongoing momentum in robust end markets

5 September 2023

DS Smith

DS Smith overall trading in line with expectations

5 September 2023

GSK plc

GSK’s Nucala accepted for review as a sJNDA in Japan

1 September 2023

Reckitt Benckiser

Reckitt Benckiser Kris Licht to take over as CEO on 1 October 2023

1 September 2023

UK Broker Ratings

Spirent Communications (SPT.L) Stock Analysis: Navigating the Tech Terrain with Resilient Growth

9 October 2025

SOFTCAT PLC (SCT.L) Stock Report: Exploring a 14.82% Potential Upside in the Tech Sector

9 October 2025

Supermarket Income REIT plc (SUPR.L): Investor Outlook Amid Market Cap Resilience

9 October 2025

Spire Healthcare Group PLC (SPI.L): Exploring a 20% Upside Potential in the Healthcare Sector

9 October 2025

Spectris PLC (SXS.L) Stock Analysis: Evaluating the Tech Sector Challenger with a 4% Return on Equity

9 October 2025

US Broker Ratings

Valmont Industries, Inc. Share Price Target ‘$288.33’, now 6.0% Upside Potential

June 28, 2024

Vertex Pharmaceuticals Incorporated Share Price Target ‘$473.61’, now -.1% Downside Potential

June 28, 2024

Ovintiv Inc. Share Price Target ‘$63.16’, now 37.4% Upside Potential

June 28, 2024

TopBuild Corp. Share Price Target ‘$465.00’, now 21.9% Upside Potential

June 28, 2024

First American Financial Corporation Share Price Target ‘$66.00’, now 24.2% Upside Potential

June 28, 2024

Mohawk Industries, Inc. Share Price Target ‘$126.63’, now 18.6% Upside Potential

June 28, 2024

Axalta Coating Systems Ltd. Share Price Target ‘$40.06’, now 17.8% Upside Potential

June 28, 2024

Merck & Co., Inc. Share Price Target ‘$142.98’, now 8.7% Upside Potential

June 28, 2024

Polaris Inc. Share Price Target ‘$97.33’, now 24.6% Upside Potential

June 28, 2024

MDU Resources Group, Inc. Share Price Target ‘$26.50’, now 5.4% Upside Potential

June 28, 2024

Range Resources Corporation Share Price Target ‘$38.62’, now 15.1% Upside Potential

June 28, 2024

Zoetis Inc. Share Price Target ‘$212.29’, now 24.2% Upside Potential

June 28, 2024

Regal Rexnord Corporation Share Price Target ‘$196.88’, now 43.9% Upside Potential

June 28, 2024

The Middleby Corporation Share Price Target ‘$168.67’, now 37.3% Upside Potential

June 28, 2024

Flowers Foods, Inc. Share Price Target ‘$24.71’, now 9.9% Upside Potential

June 28, 2024

Inspire Medical Systems, Inc. Share Price Target ‘$246.00’, now 78.4% Upside Potential

June 28, 2024

Norwegian Cruise Line Holdings Ltd. Share Price Target ‘$20.81’, now 11.9% Upside Potential

June 28, 2024

Commerce Bancshares, Inc. Share Price Target ‘$58.25’, now 7.2% Upside Potential

June 28, 2024

HashiCorp, Inc. Share Price Target ‘$34.50’, now 3.0% Upside Potential

June 28, 2024

Abbott Laboratories Share Price Target ‘$125.18’, now 19.4% Upside Potential

June 28, 2024

News and Interview Alerts

Company Presentations

Q&As

Hardman & Co

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

Green News

Drax Group completes £300m buyback and launches £75m extension tranche

9 October 2025

View all Sustainable sectors, Plcs and news >>

Search

Latest interviews

Broker Talk

Funds

Fidelity

Investing in Europe: Why investors should remain positive

8 October 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

The Diverse Income Trust Gervais Williams Eyes Big Gains from Gold, Gas and Tech (Video)

3 October 2025

View all Funds, Market Insights and news >>

FTSE 100 News

Ashtead Group

Ashtead Group achieves strong quarter with ongoing momentum in robust end markets

5 September 2023

DS Smith

DS Smith overall trading in line with expectations

5 September 2023

GSK plc

GSK’s Nucala accepted for review as a sJNDA in Japan

1 September 2023

Reckitt Benckiser

Reckitt Benckiser Kris Licht to take over as CEO on 1 October 2023

1 September 2023

UK Broker Ratings

Spirent Communications (SPT.L) Stock Analysis: Navigating the Tech Terrain with Resilient Growth

9 October 2025

SOFTCAT PLC (SCT.L) Stock Report: Exploring a 14.82% Potential Upside in the Tech Sector

9 October 2025

Supermarket Income REIT plc (SUPR.L): Investor Outlook Amid Market Cap Resilience

9 October 2025

Spire Healthcare Group PLC (SPI.L): Exploring a 20% Upside Potential in the Healthcare Sector

9 October 2025

Spectris PLC (SXS.L) Stock Analysis: Evaluating the Tech Sector Challenger with a 4% Return on Equity

9 October 2025

US Broker Ratings

Broker Ratings

Valmont Industries, Inc. Share Price Target ‘$288.33’, now 6.0% Upside Potential

28 June 2024

Broker Ratings

Vertex Pharmaceuticals Incorporated Share Price Target ‘$473.61’, now -.1% Downside Potential

28 June 2024

Broker Ratings

Ovintiv Inc. Share Price Target ‘$63.16’, now 37.4% Upside Potential

28 June 2024

Broker Ratings

TopBuild Corp. Share Price Target ‘$465.00’, now 21.9% Upside Potential

28 June 2024

Broker Ratings

First American Financial Corporation Share Price Target ‘$66.00’, now 24.2% Upside Potential

28 June 2024

Broker Ratings

Mohawk Industries, Inc. Share Price Target ‘$126.63’, now 18.6% Upside Potential

28 June 2024

Broker Ratings

Axalta Coating Systems Ltd. Share Price Target ‘$40.06’, now 17.8% Upside Potential

28 June 2024

Broker Ratings

Merck & Co., Inc. Share Price Target ‘$142.98’, now 8.7% Upside Potential

28 June 2024

Broker Ratings

Polaris Inc. Share Price Target ‘$97.33’, now 24.6% Upside Potential

28 June 2024

Broker Ratings

MDU Resources Group, Inc. Share Price Target ‘$26.50’, now 5.4% Upside Potential

28 June 2024

Broker Ratings

Range Resources Corporation Share Price Target ‘$38.62’, now 15.1% Upside Potential

28 June 2024

Broker Ratings

Zoetis Inc. Share Price Target ‘$212.29’, now 24.2% Upside Potential

28 June 2024

Broker Ratings

Regal Rexnord Corporation Share Price Target ‘$196.88’, now 43.9% Upside Potential

28 June 2024

Broker Ratings

The Middleby Corporation Share Price Target ‘$168.67’, now 37.3% Upside Potential

28 June 2024

Broker Ratings

Flowers Foods, Inc. Share Price Target ‘$24.71’, now 9.9% Upside Potential

28 June 2024

Broker Ratings

Inspire Medical Systems, Inc. Share Price Target ‘$246.00’, now 78.4% Upside Potential

28 June 2024

Broker Ratings

Norwegian Cruise Line Holdings Ltd. Share Price Target ‘$20.81’, now 11.9% Upside Potential

28 June 2024

Broker Ratings

Commerce Bancshares, Inc. Share Price Target ‘$58.25’, now 7.2% Upside Potential

28 June 2024

Broker Ratings

HashiCorp, Inc. Share Price Target ‘$34.50’, now 3.0% Upside Potential

28 June 2024

Broker Ratings

Abbott Laboratories Share Price Target ‘$125.18’, now 19.4% Upside Potential

28 June 2024

Latest Interviews

FTSE 100 News

GSK Plc

GSK DREAMM-3 phase III trial for Blenrep did not meet its primary endpoint

7 November 2022

Croda International

Croda International’s Group Finance Director to retire

7 November 2022

J Sainsburys plc

J Sainsburys profits significantly higher than pre-Covid levels

3 November 2022

RS Group deliver a strong revenue and profit performance in H1

3 November 2022

Smurfit Kappa Group plc

Smurfit Kappa achieves revenue growth of 33% to €9,724 million

2 November 2022

FTSE 250 News

medical

Mediclinic Southern Africa announces approval for the acquisition of Matlosana hospitals

7 February 2020

Pets at home

Pets at Home Group Appointment of New Chairman

7 February 2020

Private Equity Funding Tracking

Sequoia Economic Infrastructure Income Fund Limited adds to leadership team

7 February 2020

Buildings

Great Portland Estates signs innovative £450 million ESG-linked Revolving Credit Facility

6 February 2020

Assets Under Management

Ashmore Group deliver strong financial performance

6 February 2020

News and Interview Alerts

Company Presentations

Q&As

Hardman & Co

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

BrokerTalk

FTSE 100

Funds

Fidelity

Investing in Europe: Why investors should remain positive

8 October 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

The Diverse Income Trust Gervais Williams Eyes Big Gains from Gold, Gas and Tech (Video)

3 October 2025

View all Funds, Market Insights and news >>

Green News

Drax Group completes £300m buyback and launches £75m extension tranche

9 October 2025

View all Sustainable sectors, Plcs and news >>

UK Broker Ratings

Spirent Communications (SPT.L) Stock Analysis: Navigating the Tech Terrain with Resilient Growth

9 October 2025

SOFTCAT PLC (SCT.L) Stock Report: Exploring a 14.82% Potential Upside in the Tech Sector

9 October 2025

Supermarket Income REIT plc (SUPR.L): Investor Outlook Amid Market Cap Resilience

9 October 2025

Spire Healthcare Group PLC (SPI.L): Exploring a 20% Upside Potential in the Healthcare Sector

9 October 2025

Spectris PLC (SXS.L) Stock Analysis: Evaluating the Tech Sector Challenger with a 4% Return on Equity

9 October 2025